Compare Enveric Biosciences Inc (ENVB) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Xylem, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Xylem, Inc. trades at $123.19 (market cap $28.76B). The key difference: Xylem, Inc. is far larger — about 4638.7× Enveric Biosciences Inc's market cap, and Xylem, Inc. pays a 1.4% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | XYL | |
|---|---|---|
Market Cap | $6.20M | $28.76B |
Sector | Health | Industrials |
52-Week High | $17.40 | $152.95 |
52-Week Low | $1.27 | $106.34 |
Enterprise Value | $1.30M | $30.54B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
